Herbal tea-induced hepatic veno-occlusive disease in China: a case description.
作者信息
Li Bo, Gao Fabao, Liu Xinai, Pan Junzheng, Liu Lin
机构信息
West China School of Medicine, Sichuan University, Chengdu, China.
Department of Radiology, West China Hospital, Chengdu, China.
出版信息
Quant Imaging Med Surg. 2021 Aug;11(8):3882-3889. doi: 10.21037/qims-20-48.
Abstract
摘要
相似文献
1
Herbal tea-induced hepatic veno-occlusive disease in China: a case description.
Quant Imaging Med Surg. 2021 Aug;11(8):3882-3889. doi: 10.21037/qims-20-48.
2
[Hepatic veno-occlusive disease: report of a case].
J Pediatr (Rio J). 1997 Mar-Apr;73(2):115-8. doi: 10.2223/jped.518.
3
Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea.
Eur J Pediatr. 1995 Feb;154(2):112-6. doi: 10.1007/BF01991912.
4
Fatal veno-occlusive disease of the liver associated with herbal tea consumption and radiation.
Aust N Z J Med. 1984 Feb;14(1):61-2. doi: 10.1111/j.1445-5994.1984.tb03590.x.
5
Hepatic veno-occlusive disease due to toxic alkaloid herbal tea.
Lancet. 1983 Dec 10;2(8363):1360-1. doi: 10.1016/s0140-6736(83)91112-1.
6
Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea.
J Pediatr. 1988 Mar;112(3):433-6. doi: 10.1016/s0022-3476(88)80330-5.
7
Hepatic veno-occlusive disease originating in Ecuador.
Gastroenterology. 1976 Jan;70(1):105-8.
8
Veno-occlusive liver disease: a case report.
Ethiop Med J. 2012 Apr;50 Suppl 2:47-51.
9
Herbal tea induced hepatic veno-occlusive disease: quantification of toxic alkaloid exposure in adults.
Gut. 1985 Jan;26(1):101-4. doi: 10.1136/gut.26.1.101.
10
A case of veno-occlusive disease of the liver in Britain associated with herbal tea consumption.
J Clin Pathol. 1976 Sep;29(9):788-94. doi: 10.1136/jcp.29.9.788.
引用本文的文献
1
Sorting out the plants responsible for a contamination with pyrrolizidine alkaloids in spice seeds by means of LC-MS/MS and DNA barcoding: Proof of principle with cumin and anise spice seeds.
Food Chem (Oxf). 2022 Jan 1;4:100070. doi: 10.1016/j.fochms.2021.100070. eCollection 2022 Jul 30.
本文引用的文献
1
Imaging in Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
Biol Blood Marrow Transplant. 2020 Oct;26(10):1770-1779. doi: 10.1016/j.bbmt.2020.06.016. Epub 2020 Jun 25.
2
Noninvasive imaging diagnosis of sinusoidal obstruction syndrome: a pictorial review.
Insights Imaging. 2019 Nov 20;10(1):110. doi: 10.1186/s13244-019-0791-x.
3
Treatment of hepatic veno-occlusive disease in children with N-acetylcysteine.
Pediatr Blood Cancer. 2019 Feb;66(2):e27518. doi: 10.1002/pbc.27518. Epub 2018 Oct 23.
4
Soluble Thrombomodulin Attenuates Endothelial Cell Damage in Hepatic Sinusoidal Obstruction Syndrome.
In Vivo. 2018 Nov-Dec;32(6):1409-1417. doi: 10.21873/invivo.11393.
5
Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure.
Int J Hematol Oncol. 2017 Nov;6(3):75-93. doi: 10.2217/ijh-2017-0015. Epub 2017 Aug 11.
6
Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids.
Biomed Res Int. 2018 Jun 13;2018:9804582. doi: 10.1155/2018/9804582. eCollection 2018.
7
Clinical diagnosis of veno-occlusive disease using contrast enhanced ultrasound.
Bone Marrow Transplant. 2018 Oct;53(10):1369-1371. doi: 10.1038/s41409-018-0198-1. Epub 2018 May 22.
8
Hepatic veno-occlusive disease related to Gynura segetum: A case report.
Medicine (Baltimore). 2018 Apr;97(17):e0552. doi: 10.1097/MD.0000000000010552.
9
CT Features of Hepatic Veno-occlusive Disease: A Meta-analysis.
Acad Radiol. 2018 Mar;25(3):328-337. doi: 10.1016/j.acra.2017.10.012. Epub 2017 Nov 27.
10
First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.
Arch Toxicol. 2017 Dec;91(12):3913-3925. doi: 10.1007/s00204-017-2013-y. Epub 2017 Jun 15.
Zotero 插件